ScandiDos AB (publ) (SDOS.ST)
SEK 1.64
(-1.2%)
SEK 1.64
(-1.2%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 22.69 Million SEK | 1.5% |
| 2022 | 22.35 Million SEK | 20.34% |
| 2021 | 18.57 Million SEK | -4.05% |
| 2020 | 19.36 Million SEK | -3.62% |
| 2019 | 20.08 Million SEK | 17.74% |
| 2018 | 17.06 Million SEK | 12.72% |
| 2017 | 15.13 Million SEK | 1.64% |
| 2016 | 14.89 Million SEK | 28.65% |
| 2015 | 11.57 Million SEK | 52.0% |
| 2014 | 7.61 Million SEK | -11.13% |
| 2013 | 8.57 Million SEK | 71.02% |
| 2012 | 5.01 Million SEK | -16.83% |
| 2011 | 6.02 Million SEK | -2.76% |
| 2010 | 6.19 Million SEK | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 22.12 Million SEK | 3.41% |
| 2023 Q3 | 23.08 Million SEK | 1.95% |
| 2023 FY | 22.69 Million SEK | 1.5% |
| 2023 Q1 | 21.68 Million SEK | -2.98% |
| 2023 Q4 | 22.69 Million SEK | -1.72% |
| 2023 Q2 | 22.64 Million SEK | 4.41% |
| 2022 Q1 | 21.98 Million SEK | 18.36% |
| 2022 Q2 | 23.41 Million SEK | 6.48% |
| 2022 FY | 22.35 Million SEK | 20.34% |
| 2022 Q3 | 22.84 Million SEK | -2.41% |
| 2022 Q4 | 22.35 Million SEK | -2.16% |
| 2021 Q3 | 19.73 Million SEK | -2.26% |
| 2021 Q4 | 18.57 Million SEK | -5.85% |
| 2021 FY | 18.57 Million SEK | -4.05% |
| 2021 Q1 | 19.14 Million SEK | -1.11% |
| 2021 Q2 | 20.18 Million SEK | 5.43% |
| 2020 Q2 | 19.66 Million SEK | -0.74% |
| 2020 FY | 19.36 Million SEK | -3.62% |
| 2020 Q1 | 19.81 Million SEK | -1.36% |
| 2020 Q4 | 19.36 Million SEK | 0.83% |
| 2020 Q3 | 19.2 Million SEK | -2.38% |
| 2019 Q3 | 20.12 Million SEK | 1.48% |
| 2019 FY | 20.08 Million SEK | 17.74% |
| 2019 Q4 | 20.08 Million SEK | -0.19% |
| 2019 Q2 | 19.83 Million SEK | 0.38% |
| 2019 Q1 | 19.75 Million SEK | 15.8% |
| 2018 Q1 | 17.82 Million SEK | 17.78% |
| 2018 FY | 17.06 Million SEK | 12.72% |
| 2018 Q4 | 17.06 Million SEK | -7.85% |
| 2018 Q3 | 18.51 Million SEK | -1.35% |
| 2018 Q2 | 18.77 Million SEK | 5.28% |
| 2017 Q1 | 15.85 Million SEK | 6.47% |
| 2017 Q4 | 15.13 Million SEK | -10.04% |
| 2017 Q3 | 16.82 Million SEK | 3.23% |
| 2017 Q2 | 16.3 Million SEK | 2.79% |
| 2017 FY | 15.13 Million SEK | 1.64% |
| 2016 Q4 | 14.89 Million SEK | 27.99% |
| 2016 Q2 | 12.93 Million SEK | 3.97% |
| 2016 Q3 | 11.63 Million SEK | -10.04% |
| 2016 Q1 | 12.44 Million SEK | 7.46% |
| 2016 FY | 14.89 Million SEK | 28.65% |
| 2015 Q2 | 10.23 Million SEK | 4.69% |
| 2015 Q4 | 11.57 Million SEK | 7.76% |
| 2015 Q3 | 10.74 Million SEK | 4.94% |
| 2015 FY | 11.57 Million SEK | 52.0% |
| 2015 Q1 | 9.77 Million SEK | 28.37% |
| 2014 FY | 7.61 Million SEK | -11.13% |
| 2014 Q3 | 7.7 Million SEK | -5.85% |
| 2014 Q2 | 8.18 Million SEK | -8.34% |
| 2014 Q1 | 8.93 Million SEK | 4.24% |
| 2014 Q4 | 7.61 Million SEK | -1.21% |
| 2013 Q4 | 8.57 Million SEK | 16.82% |
| 2013 FY | 8.57 Million SEK | 71.02% |
| 2013 Q1 | - SEK | -100.0% |
| 2013 Q3 | 7.33 Million SEK | 0.0% |
| 2012 Q4 | 5.01 Million SEK | 0.0% |
| 2012 FY | 5.01 Million SEK | -16.83% |
| 2011 FY | 6.02 Million SEK | -2.76% |
| 2010 FY | 6.19 Million SEK | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Acarix AB (publ) | 6.83 Million SEK | -231.774% |
| ADDvise Group AB (publ) | 121.2 Million SEK | 81.279% |
| ADDvise Group AB (publ) | 121.2 Million SEK | 81.279% |
| Arcoma AB | 28.02 Million SEK | 19.042% |
| Bactiguard Holding AB (publ) | 29.64 Million SEK | 23.464% |
| BICO Group AB (publ) | 493.1 Million SEK | 95.398% |
| Boule Diagnostics AB (publ) | 62.4 Million SEK | 63.638% |
| CellaVision AB (publ) | 126.03 Million SEK | 81.997% |
| Clinical Laserthermia Systems AB (publ) | 6.11 Million SEK | -271.055% |
| Chordate Medical Holding AB (publ) | 1.77 Million SEK | -1181.254% |
| C-Rad AB (publ) | 64.09 Million SEK | 64.602% |
| Duearity AB (publ) | 4.15 Million SEK | -445.564% |
| Dignitana AB (publ) | 7.41 Million SEK | -206.084% |
| Episurf Medical AB (publ) | 3.7 Million SEK | -513.243% |
| Getinge AB (publ) | 6.41 Billion SEK | 99.646% |
| Scandinavian Real Heart AB (Publ) | -1.68 Million SEK | 1447.891% |
| Iconovo AB (publ) | -4.86 Million SEK | 566.68% |
| Integrum AB (publ) | 22.36 Million SEK | -1.467% |
| Luxbright AB (publ) | 8000.00 SEK | -283525.0% |
| Mentice AB (publ) | 14.1 Million SEK | -60.876% |
| OssDsign AB (publ) | 4.3 Million SEK | -427.184% |
| Paxman AB (publ) | 19.99 Million SEK | -13.456% |
| Promimic AB (publ) | 330 Thousand SEK | -6775.758% |
| Qlife Holding AB (publ) | 7.29 Million SEK | -211.163% |
| SciBase Holding AB (publ) | 11.91 Million SEK | -90.368% |
| Sectra AB (publ) | 36.59 Million SEK | 37.989% |
| Sedana Medical AB (publ) | 42.97 Million SEK | 47.202% |
| Senzime AB (publ) | 20.34 Million SEK | -11.554% |
| SpectraCure AB (publ) | 1.00 SEK | -2268999900.0% |
| Stille AB | 66.55 Million SEK | 65.907% |
| Vitrolife AB (publ) | 413 Million SEK | 94.506% |
| Xvivo Perfusion AB (publ) | 141.6 Million SEK | 83.976% |